These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Comparison of reboxetine and sertraline in terms of efficacy and safety in major depressive disorder]. Eker SS; Akkaya C; Akgöz S; Sarandöl A; Kirli S Turk Psikiyatri Derg; 2005; 16(3):153-63. PubMed ID: 16180148 [TBL] [Abstract][Full Text] [Related]
8. Sertraline in the treatment of depressive disorders in patients with Parkinson's disease. Marino S; Sessa E; Di Lorenzo G; Digangi G; Alagna A; Bramanti P; Di Bella P Neurol Sci; 2008 Dec; 29(6):391-5. PubMed ID: 19002650 [TBL] [Abstract][Full Text] [Related]
9. Japanese versions of the executive interview (J-EXIT25) and the executive clock drawing task (J-CLOX) for older people. Matsuoka T; Kato Y; Taniguchi S; Ogawa M; Fujimoto H; Okamura A; Shibata K; Nakamura K; Uchida H; Nakaaki S; Koumi H; Mimura M; Fukui K; Narumoto J Int Psychogeriatr; 2014 Aug; 26(8):1387-97. PubMed ID: 24832196 [TBL] [Abstract][Full Text] [Related]
10. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. Keller MB; Gelenberg AJ; Hirschfeld RM; Rush AJ; Thase ME; Kocsis JH; Markowitz JC; Fawcett JA; Koran LM; Klein DN; Russell JM; Kornstein SG; McCullough JP; Davis SM; Harrison WM J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606 [TBL] [Abstract][Full Text] [Related]
11. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. Ventura D; Armstrong EP; Skrepnek GH; Haim Erder M Curr Med Res Opin; 2007 Feb; 23(2):245-50. PubMed ID: 17288677 [TBL] [Abstract][Full Text] [Related]
12. [Toxic hepatitis following sequential treatment with cotrimoxazol, levofloxacin, doxycycline and sertraline in a patient with a respiratory infection]. García-Aparicio J; Herrero-Herrero JI Farm Hosp; 2010; 34(3):152-4. PubMed ID: 20471573 [No Abstract] [Full Text] [Related]
13. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Lyketsos CG; DelCampo L; Steinberg M; Miles Q; Steele CD; Munro C; Baker AS; Sheppard JM; Frangakis C; Brandt J; Rabins PV Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778 [TBL] [Abstract][Full Text] [Related]
14. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression. Miner CM; Brown EB; Gonzales JS; Munir R J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison. Matreja PS; Badyal DK; Khosla P; Deswal RS Hum Psychopharmacol; 2007 Oct; 22(7):477-82. PubMed ID: 17647298 [TBL] [Abstract][Full Text] [Related]
16. Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline. Culang-Reinlieb ME; Sneed JR; Keilp JG; Roose SP Int J Geriatr Psychiatry; 2012 Aug; 27(8):777-84. PubMed ID: 21919060 [TBL] [Abstract][Full Text] [Related]
17. Sertraline treatment of elderly patients with depression and cognitive impairment. Devanand DP; Pelton GH; Marston K; Camacho Y; Roose SP; Stern Y; Sackeim HA Int J Geriatr Psychiatry; 2003 Feb; 18(2):123-30. PubMed ID: 12571820 [TBL] [Abstract][Full Text] [Related]
18. Sertraline and venlafaxine: new indication. Prevention of recurrent depression: no advance. Prescrire Int; 2005 Feb; 14(75):19-20. PubMed ID: 15751171 [TBL] [Abstract][Full Text] [Related]
19. An open-label trial of sertraline for the treatment of major depression in primary care. Taragano F; Lyketsos CG; Paz J; Schapira M; Comesaña Díaz E; Klimovsky S Ann Clin Psychiatry; 1999 Jun; 11(2):67-71. PubMed ID: 10440523 [TBL] [Abstract][Full Text] [Related]
20. Psychotic depression, subcortical arteriosclerotic encephalopathy and holocaust-conditioned posttraumatic stress disorder. Kropp S; Schlimme J; Schneider U Aust N Z J Psychiatry; 2001 Feb; 35(1):129. PubMed ID: 11270447 [No Abstract] [Full Text] [Related] [Next] [New Search]